Huangshan Novel Co.,Ltd Logo

Huangshan Novel Co.,Ltd

002014.SZ

(4.0)
Stock Price

10,04 CNY

11.48% ROA

17.67% ROE

14.91x PER

Market Cap.

6.012.696.690,00 CNY

36.63% DER

5.49% Yield

12.03% NPM

Huangshan Novel Co.,Ltd Stock Analysis

Huangshan Novel Co.,Ltd Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Huangshan Novel Co.,Ltd Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (18.14%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

3 DER

The stock has a minimal amount of debt (24%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Revenue Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

5 Net Profit Growth

Over the last five years, this company's net profit has shown continuous growth, reflecting a robust financial performance and making it an attractive choice for potential investors.

6 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

7 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

8 PBV

The stock's PBV ratio (2.1x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

9 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (63), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

10 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

11 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

Huangshan Novel Co.,Ltd Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Huangshan Novel Co.,Ltd Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Huangshan Novel Co.,Ltd Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Huangshan Novel Co.,Ltd Revenue
Year Revenue Growth
2001 247.075.434
2002 358.588.085 31.1%
2003 431.003.451 16.8%
2004 485.083.912 11.15%
2005 610.814.223 20.58%
2006 718.899.070 15.03%
2007 1.045.570.737 31.24%
2008 1.219.428.116 14.26%
2009 1.054.575.342 -15.63%
2010 1.276.392.235 17.38%
2011 1.513.086.127 15.64%
2012 1.521.013.203 0.52%
2013 1.618.458.051 6.02%
2014 1.668.452.272 3%
2015 1.783.867.801 6.47%
2016 1.904.193.777 6.32%
2017 2.008.242.605 5.18%
2018 2.332.267.545 13.89%
2019 2.599.724.041 10.29%
2020 2.737.497.376 5.03%
2021 3.023.694.551 9.47%
2022 3.304.135.248 8.49%
2023 3.494.768.265 5.45%
2023 3.378.793.651 -3.43%
2024 3.242.139.536 -4.21%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Huangshan Novel Co.,Ltd Research and Development Expenses
Year Research and Development Expenses Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 7.368.679 100%
2011 7.562.866 2.57%
2012 8.224.615 8.05%
2013 9.330.753 11.85%
2014 15.836.396 41.08%
2015 21.339.116 25.79%
2016 29.449.724 27.54%
2017 45.928.508 35.88%
2018 65.896.663 30.3%
2019 101.190.953 34.88%
2020 112.772.451 10.27%
2021 121.105.571 6.88%
2022 134.981.082 10.28%
2023 164.664.366 18.03%
2023 144.995.836 -13.56%
2024 134.034.020 -8.18%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Huangshan Novel Co.,Ltd General and Administrative Expenses
Year General and Administrative Expenses Growth
2001 9.579.073
2002 14.740.915 35.02%
2003 17.233.518 14.46%
2004 19.869.329 13.27%
2005 24.608.498 19.26%
2006 27.048.747 9.02%
2007 42.549.008 36.43%
2008 51.298.482 17.06%
2009 55.370.649 7.35%
2010 10.856.621 -410.02%
2011 13.880.695 21.79%
2012 13.454.729 -3.17%
2013 12.965.510 -3.77%
2014 12.829.952 -1.06%
2015 22.144.559 42.06%
2016 15.003.517 -47.6%
2017 14.971.565 -0.21%
2018 16.379.488 8.6%
2019 19.404.037 15.59%
2020 45.703.775 57.54%
2021 18.858.710 -142.35%
2022 18.269.345 -3.23%
2023 344.956.804 94.7%
2023 22.122.225 -1459.32%
2024 -100.353.526 122.04%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Huangshan Novel Co.,Ltd EBITDA
Year EBITDA Growth
2001 24.758.435
2002 52.952.960 53.24%
2003 66.845.362 20.78%
2004 68.078.926 1.81%
2005 73.735.062 7.67%
2006 90.389.885 18.43%
2007 109.561.183 17.5%
2008 133.299.270 17.81%
2009 174.186.122 23.47%
2010 186.067.687 6.39%
2011 222.151.579 16.24%
2012 270.221.762 17.79%
2013 272.310.178 0.77%
2014 246.830.307 -10.32%
2015 306.284.169 19.41%
2016 356.614.292 14.11%
2017 341.911.972 -4.3%
2018 371.288.589 7.91%
2019 437.591.869 15.15%
2020 478.588.427 8.57%
2021 498.204.280 3.94%
2022 554.291.314 10.12%
2023 573.272.021 3.31%
2023 663.461.318 13.59%
2024 556.970.520 -19.12%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Huangshan Novel Co.,Ltd Gross Profit
Year Gross Profit Growth
2001 47.916.002
2002 75.974.647 36.93%
2003 92.367.612 17.75%
2004 93.282.075 0.98%
2005 104.557.005 10.78%
2006 118.249.403 11.58%
2007 161.729.841 26.88%
2008 207.029.755 21.88%
2009 237.526.084 12.84%
2010 251.099.386 5.41%
2011 302.440.875 16.98%
2012 337.071.832 10.27%
2013 333.685.700 -1.01%
2014 314.265.081 -6.18%
2015 378.851.888 17.05%
2016 444.082.734 14.69%
2017 455.963.579 2.61%
2018 511.969.275 10.94%
2019 628.988.773 18.6%
2020 666.847.240 5.68%
2021 672.431.241 0.83%
2022 733.535.967 8.33%
2023 894.052.718 17.95%
2023 833.289.023 -7.29%
2024 693.319.140 -20.19%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Huangshan Novel Co.,Ltd Net Profit
Year Net Profit Growth
2001 21.270.298
2002 35.340.560 39.81%
2003 42.761.027 17.35%
2004 43.680.911 2.11%
2005 44.112.193 0.98%
2006 47.255.231 6.65%
2007 53.811.371 12.18%
2008 68.050.165 20.92%
2009 100.690.892 32.42%
2010 121.235.153 16.95%
2011 147.844.170 18%
2012 178.770.833 17.3%
2013 176.269.220 -1.42%
2014 154.491.070 -14.1%
2015 178.539.016 13.47%
2016 202.710.560 11.92%
2017 205.483.203 1.35%
2018 225.324.381 8.81%
2019 269.116.549 16.27%
2020 303.032.141 11.19%
2021 315.913.031 4.08%
2022 362.828.955 12.93%
2023 464.154.551 21.83%
2023 408.045.340 -13.75%
2024 374.973.716 -8.82%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Huangshan Novel Co.,Ltd Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 1 0%
2021 1 0%
2022 1 0%
2023 1 0%
2023 1 0%
2024 1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Huangshan Novel Co.,Ltd Free Cashflow
Year Free Cashflow Growth
2002 8.992.389
2003 23.533.787 61.79%
2004 -45.488.134 151.74%
2005 -19.618.215 -131.87%
2006 2.775.242 806.9%
2007 45.797.010 93.94%
2008 71.677.676 36.11%
2009 57.495.736 -24.67%
2010 46.322.684 -24.12%
2011 49.802.511 6.99%
2012 43.872.652 -13.52%
2013 -55.046.205 179.7%
2014 40.781.576 234.98%
2015 91.804.598 55.58%
2016 179.285.207 48.79%
2017 200.829.406 10.73%
2018 175.585.958 -14.38%
2019 264.911.310 33.72%
2020 287.324.577 7.8%
2021 55.674.381 -416.08%
2022 235.186.597 76.33%
2023 405.649.081 42.02%
2023 171.093.276 -137.09%
2024 286.299.828 40.24%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Huangshan Novel Co.,Ltd Operating Cashflow
Year Operating Cashflow Growth
2002 38.659.183
2003 49.348.774 21.66%
2004 48.299.766 -2.17%
2005 44.614.290 -8.26%
2006 64.806.479 31.16%
2007 83.957.648 22.81%
2008 151.200.923 44.47%
2009 116.261.750 -30.05%
2010 125.460.797 7.33%
2011 197.379.903 36.44%
2012 185.638.196 -6.33%
2013 117.520.977 -57.96%
2014 187.818.118 37.43%
2015 247.696.629 24.17%
2016 280.628.298 11.73%
2017 277.299.915 -1.2%
2018 323.833.456 14.37%
2019 428.432.150 24.41%
2020 548.623.540 21.91%
2021 296.233.778 -85.2%
2022 543.555.266 45.5%
2023 515.342.436 -5.47%
2023 199.045.289 -158.91%
2024 300.665.108 33.8%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Huangshan Novel Co.,Ltd Capital Expenditure
Year Capital Expenditure Growth
2002 29.666.793
2003 25.814.987 -14.92%
2004 93.787.900 72.48%
2005 64.232.505 -46.01%
2006 62.031.236 -3.55%
2007 38.160.638 -62.55%
2008 79.523.247 52.01%
2009 58.766.014 -35.32%
2010 79.138.112 25.74%
2011 147.577.391 46.38%
2012 141.765.544 -4.1%
2013 172.567.182 17.85%
2014 147.036.542 -17.36%
2015 155.892.030 5.68%
2016 101.343.091 -53.83%
2017 76.470.508 -32.53%
2018 148.247.497 48.42%
2019 163.520.839 9.34%
2020 261.298.962 37.42%
2021 240.559.397 -8.62%
2022 308.368.669 21.99%
2023 109.693.355 -181.12%
2023 27.952.013 -292.43%
2024 14.365.280 -94.58%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Huangshan Novel Co.,Ltd Equity
Year Equity Growth
2001 92.770.850
2002 111.525.740 16.82%
2003 144.546.768 22.84%
2004 347.846.953 58.45%
2005 363.371.643 4.27%
2006 375.214.065 3.16%
2007 589.896.062 36.39%
2008 629.706.384 6.32%
2009 698.529.360 9.85%
2010 770.861.046 9.38%
2011 866.088.462 11%
2012 1.414.350.587 38.76%
2013 1.506.217.899 6.1%
2014 1.560.570.231 3.48%
2015 1.632.622.568 4.41%
2016 1.755.755.862 7.01%
2017 1.796.375.097 2.26%
2018 1.873.114.719 4.1%
2019 1.895.175.171 1.16%
2020 2.031.479.327 6.71%
2021 2.171.469.314 6.45%
2022 2.324.799.143 6.6%
2023 2.504.691.617 7.18%
2023 2.388.573.379 -4.86%
2024 2.346.594.868 -1.79%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Huangshan Novel Co.,Ltd Assets
Year Assets Growth
2001 187.331.520
2002 221.394.291 15.39%
2003 254.611.375 13.05%
2004 479.962.407 46.95%
2005 491.324.782 2.31%
2006 565.302.371 13.09%
2007 845.799.066 33.16%
2008 910.603.524 7.12%
2009 975.004.728 6.61%
2010 1.103.938.640 11.68%
2011 1.313.739.661 15.97%
2012 1.831.582.485 28.27%
2013 1.894.855.554 3.34%
2014 1.966.051.220 3.62%
2015 2.078.267.344 5.4%
2016 2.276.925.035 8.72%
2017 2.401.280.827 5.18%
2018 2.536.881.163 5.35%
2019 2.545.851.954 0.35%
2020 2.954.630.295 13.84%
2021 3.009.639.907 1.83%
2022 3.572.752.541 15.76%
2023 3.903.428.541 8.47%
2023 3.685.255.424 -5.92%
2024 3.663.363.710 -0.6%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Huangshan Novel Co.,Ltd Liabilities
Year Liabilities Growth
2001 94.560.670
2002 109.868.550 13.93%
2003 110.064.607 0.18%
2004 132.115.453 16.69%
2005 127.953.139 -3.25%
2006 190.088.306 32.69%
2007 255.903.002 25.72%
2008 280.897.140 8.9%
2009 276.475.368 -1.6%
2010 333.077.593 16.99%
2011 447.651.198 25.59%
2012 417.231.897 -7.29%
2013 388.637.654 -7.36%
2014 405.480.988 4.15%
2015 445.644.775 9.01%
2016 521.169.173 14.49%
2017 604.905.728 13.84%
2018 663.766.443 8.87%
2019 650.676.782 -2.01%
2020 923.150.967 29.52%
2021 838.170.592 -10.14%
2022 1.247.953.397 32.84%
2023 1.398.736.923 10.78%
2023 1.296.682.045 -7.87%
2024 1.281.755.453 -1.16%

Huangshan Novel Co.,Ltd Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
5.58
Net Income per Share
0.67
Price to Earning Ratio
14.91x
Price To Sales Ratio
1.76x
POCF Ratio
8.63
PFCF Ratio
10.11
Price to Book Ratio
2.66
EV to Sales
1.79
EV Over EBITDA
11.51
EV to Operating CashFlow
8.63
EV to FreeCashFlow
10.31
Earnings Yield
0.07
FreeCashFlow Yield
0.1
Market Cap
6,01 Bil.
Enterprise Value
6,13 Bil.
Graham Number
7.53
Graham NetNet
1.01

Income Statement Metrics

Net Income per Share
0.67
Income Quality
1.73
ROE
0.18
Return On Assets
0.11
Return On Capital Employed
0.18
Net Income per EBT
0.89
EBT Per Ebit
1.02
Ebit per Revenue
0.13
Effective Tax Rate
0.1

Margins

Sales, General, & Administrative to Revenue
0.01
Research & Developement to Revenue
0.04
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.23
Operating Profit Margin
0.13
Pretax Profit Margin
0.14
Net Profit Margin
0.12

Dividends

Dividend Yield
0.05
Dividend Yield %
5.49
Payout Ratio
1.44
Dividend Per Share
0.55

Operating Metrics

Operating Cashflow per Share
1.16
Free CashFlow per Share
0.97
Capex to Operating CashFlow
0.16
Capex to Revenue
0.03
Capex to Depreciation
2.33
Return on Invested Capital
0.13
Return on Tangible Assets
0.11
Days Sales Outstanding
71.93
Days Payables Outstanding
34.2
Days of Inventory on Hand
43.43
Receivables Turnover
5.07
Payables Turnover
10.67
Inventory Turnover
8.4
Capex per Share
0.19

Balance Sheet

Cash per Share
2,03
Book Value per Share
3,89
Tangible Book Value per Share
3.76
Shareholders Equity per Share
3.76
Interest Debt per Share
1.41
Debt to Equity
0.37
Debt to Assets
0.23
Net Debt to EBITDA
0.22
Current Ratio
1.98
Tangible Asset Value
2,30 Bil.
Net Current Asset Value
0,98 Bil.
Invested Capital
2361720361
Working Capital
1,12 Bil.
Intangibles to Total Assets
0.02
Average Receivables
0,74 Bil.
Average Payables
0,33 Bil.
Average Inventory
295172635.5
Debt to Market Cap
0.14

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Huangshan Novel Co.,Ltd Dividends
Year Dividends Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 1 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 1 0%
2022 1 0%
2023 0 0%
2024 1 0%

Huangshan Novel Co.,Ltd Profile

About Huangshan Novel Co.,Ltd

Huangshan Novel Co., Ltd. manufactures and sells packaging materials primarily in China. The company's packaging materials include plastic color-printing, laminating flexible, vacuum metallized and multi-functional film, medical packaging, breathable and protective membrane, and injection molding materials. Its products are used in foodstuff, daily chemicals, pharmaceutical, agrochemicals, electronics, building materials, and other fields. The company also exports its products to Europe, the United States, Mexico, Japan, the Middle East, and rest of Asia. Huangshan Novel Co., Ltd. was founded in 1992 and is based in Huangshan, China.

CEO
Mr. Zuben Bao
Employee
2.280
Address
No. 188 Huizhou East Road
Huangshan, 245900

Huangshan Novel Co.,Ltd Executives & BODs

Huangshan Novel Co.,Ltd Executives & BODs
# Name Age
1 Mr. Yongliang Tang
Board Secretary
70
2 Mr. Changchun Wang
Deputy General Manager
70
3 Mr. Xufeng Wu
Deputy GM and Financial Controller
70
4 Mr. Xu Wu
Financial Manager
70
5 Mr. Zuben Bao
GM & Director
70
6 Mr. Jian Pan
Deputy GM & Director
70

Huangshan Novel Co.,Ltd Competitors